Steven Van Damme
Edited
Iโ€™ve added $UNH (UnitedHealth) to my portfolio this week, and hereโ€™s why I believe itโ€™s a compelling long-term play: ๐Ÿญ. ๐™Ž๐™ข๐™–๐™ง๐™ฉ ๐™ˆ๐™ค๐™ฃ๐™š๐™ฎ ๐™„๐™จ ๐™ˆ๐™ค๐™ซ๐™ž๐™ฃ๐™œ ๐™„๐™ฃ Two of the most respected investors in the worldโ€”๐™’๐™–๐™ง๐™ง๐™š๐™ฃ ๐˜ฝ๐™ช๐™›๐™›๐™š๐™ฉ๐™ฉโ€™๐™จ ๐˜ฝ๐™š๐™ง๐™ ๐™จ๐™๐™ž๐™ง๐™š ๐™ƒ๐™–๐™ฉ๐™๐™–๐™ฌ๐™–๐™ฎ and ๐˜ฟ๐™–๐™ซ๐™ž๐™™ ๐™๐™š๐™ฅ๐™ฅ๐™š๐™งโ€™๐™จ ๐˜ผ๐™ฅ๐™ฅ๐™–๐™ก๐™ค๐™ค๐™จ๐™– ๐™‡๐™‹โ€”have recently built significant positions in UnitedHealth. Berkshire quietly accumulated over ๐Ÿฑ ๐™ข๐™ž๐™ก๐™ก๐™ž๐™ค๐™ฃ ๐™จ๐™๐™–๐™ง๐™š๐™จ ๐™ฌ๐™ค๐™ง๐™ฉ๐™ $๐Ÿญ.๐Ÿฒ๐˜ฝ, while Appaloosa increased its stake, making $UNH one of its top holdings at nearly ๐Ÿญ๐Ÿฎ% ๐™ค๐™› ๐™ž๐™ฉ๐™จ ๐™ฅ๐™ค๐™ง๐™ฉ๐™›๐™ค๐™ก๐™ž๐™ค. David Tepper is known for his exceptional performance over decades. Appaloosa has delivered ๐Ÿญ๐Ÿฑ๐Ÿต% ๐™ง๐™š๐™ฉ๐™ช๐™ง๐™ฃ๐™จ ๐™ค๐™ซ๐™š๐™ง ๐™ฉ๐™๐™š ๐™ฅ๐™–๐™จ๐™ฉ ๐Ÿฑ ๐™ฎ๐™š๐™–๐™ง๐™จ ๐™–๐™ฃ๐™™ ๐Ÿฎ๐Ÿฎ๐Ÿฒ% ๐™ค๐™ซ๐™š๐™ง ๐Ÿญ๐Ÿฌ ๐™ฎ๐™š๐™–๐™ง๐™จ, far outpacing the market. If a fund with that kind of history commits such a large allocation to UNH, it signals strong conviction. ๐Ÿฎ. ๐˜ผ ๐˜พ๐™ก๐™–๐™จ๐™จ๐™ž๐™˜ ๐˜พ๐™ค๐™ฃ๐™ฉ๐™ง๐™–๐™ง๐™ž๐™–๐™ฃ ๐™Š๐™ฅ๐™ฅ๐™ค๐™ง๐™ฉ๐™ช๐™ฃ๐™ž๐™ฉ๐™ฎ UnitedHealth has faced headwinds in 2025โ€”rising medical costs, regulatory scrutiny, and leadership changesโ€”but thatโ€™s exactly why the stock traded at a steep discount earlier this year. Buffettโ€™s move signals confidence that the market has overshot on pessimism. ๐Ÿฏ. ๐™Ž๐™ฉ๐™ง๐™ค๐™ฃ๐™œ ๐™๐™ช๐™ฃ๐™™๐™–๐™ข๐™š๐™ฃ๐™ฉ๐™–๐™ก๐™จ & ๐™‚๐™ง๐™ค๐™ฌ๐™ฉ๐™ ๐˜ฟ๐™ง๐™ž๐™ซ๐™š๐™ง๐™จ Despite short-term challenges, $UNH remains the ๐™ก๐™–๐™ง๐™œ๐™š๐™จ๐™ฉ ๐™.๐™Ž. ๐™๐™š๐™–๐™ก๐™ฉ๐™ ๐™ž๐™ฃ๐™จ๐™ช๐™ง๐™š๐™ง with unmatched scale and vertical integration through Optum. Long-term tailwinds like an aging population, growing Medicare Advantage enrollment, and tech-driven cost efficiencies position it for sustainable growth. Analysts project ๐™™๐™ค๐™ช๐™—๐™ก๐™š-๐™™๐™ž๐™œ๐™ž๐™ฉ ๐™€๐™‹๐™Ž ๐™œ๐™ง๐™ค๐™ฌ๐™ฉ๐™ and continued dividend increases (whatinsights.com/health-wellness/unh-stock/). For me, this is a ๐™๐™ž๐™œ๐™-๐™ฆ๐™ช๐™–๐™ก๐™ž๐™ฉ๐™ฎ ๐™—๐™ช๐™จ๐™ž๐™ฃ๐™š๐™จ๐™จ ๐™–๐™ฉ ๐™– ๐™ง๐™š๐™–๐™จ๐™ค๐™ฃ๐™–๐™—๐™ก๐™š ๐™ฅ๐™ง๐™ž๐™˜๐™š, backed by some of the smartest money on Wall Street. Iโ€™m holding this for the long term.
1 Mentioned
null
.